Coronavirus May Boost Policy Efforts To Enhance US Drug, Medical Supply Production

 
• By Derrick Gingery
  
United States Capitol Building in Washington DC USA
FDA officials are determining whether API export restrictions imposed in India will affect the US drug supply. • Source: File photo
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Manufacturing

More from Compliance